Giant tongue leading to dysphagia in light chain amyloidosis patient

Main Article Content

Juan José Gómez-Piña http://orcid.org/0000-0003-2955-6152
Dulce Mariana Quiroz http://orcid.org/0000-0002-2033-4716
Amairani Sierra-Hernandez http://orcid.org/0000-0002-5782-0531
Sergio Alberto Mendoza-Álvarez http://orcid.org/0000-0002-4980-1162
Olga Lidia Vera-Lastra http://orcid.org/0000-0002-8729-9775

Keywords

Congo Red, Amyloidosis, Macroglossia

Abstract

Introduction: Macroglossia as a clinical manifestation of systemic amyloidosis is a rare condition, occurring in less than 9% of all types of amyloidosis. The aim of this report is to present the diagnostic approach of a patient with macroglossia, providing a systematic approach and considering relevant diagnostic possibilities during their evaluation.


Clinical case: We present the case of a 60-year-old man who presented with a progressively enlarging giant tongue for six months, causing dysphagia and reduced oral opening. A tongue biopsy was taken, which histopathologically exhibited homogenous eosinophilic amyloid-like material. Congo red staining showed amyloid material with red dye under light microscopy and apple-green birefringence under polarized light. Bone marrow biopsy showed 30% plasma cells, allowing for a definitive diagnosis of soft tissue amyloidosis. Although it is a benign lesion, localized amyloidosis should be differentiated from systemic forms.


Conclusions: The approach of patients with macroglossia is complex due to the diagnostic possibilities, from endo-crinological causes, neoplastic, and even by deposit; Being an isolated sign in a patient is a challenge in its approach, because the involvement of the airway is the main complication to avoid in these patients.

Abstract 63 | PDF (Spanish) Downloads 21

References

Muniyan S, Nair Sreela LS, Mathew P, et al. Macroglossia Associated With Primary Systemic Amyloidosis - Case Report With Unusual Clinical Presentation. J Ayub Med Coll Abbottabad. 2022;34(1):197-9. doi: 10.55519/JAMC-01-9317.

Merlini G, Seldin DC, Gertz MA. Amyloidosis: Pathogenesis And New Therapeutic Options. J Clin Oncol. 2011;29(14):1924-33. doi: 10.1200/JCO.2010.32.2271.

Muchtar E, Gertz MA, Kyle RA, et al. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing. Mayo Clin Proc. 2019;94(3):472-83.

doi: 10.1016/j.mayocp.2018.08.024.

Shahbaz A, Aziz K, Umair M, et al. Amyloidosis Presenting with Macroglossia. Cureus. 2018;10(8):1-4. doi:10.7759/cureus.3185.

Ehman EC, El-Sady MS, Kijewski MF, et al. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019;60(9):1234-9. doi: 10.2967/jnumed.118.221770.

Maturana-Ramírez A, Ortega AV, Labbé FC, et al. Macroglossia, the first manifestation of systemic amyloidosis associated with multiple myeloma: Case report. J Stomatol Oral Maxillofac Surg. 2018;119(6):514-7. doi: 10.1016/j.jormas.2018.06.009.

Oruba Z, Kaczmarzyk T, Urbańczyk K, et al. Intraoral manifestation of systemic AL amyloidosis with unique microscopic presentation of intracellular amyloid deposition in striated muscles. Pol J Pathol. 2018;69(2):200-4. doi: 10.5114/pjp.2018.76705.

Takumi K, Staziaki PV, Hito R, et al. Amyloidosis in the head and neck: CT findings with clinicopathological correlation. Eur J Radiol. 2020;128:1-8. doi:10.1016/j.ejrad.2020.109034.

Picciani B, Gornic C, Cunha KS, et al. Lingual amyloidosis associated to long-term hemodialysis: Two case reports. Spec Care Dentist. 2018;38(4):434-8. doi: 10.1111/scd.12320.

Vaxman I, Gertz M. When to Suspect a Diagnosis of Amyloidosis. Acta Haematol. 2020;143(4):304-11. doi: 10.1159/000506617.

Skinner M, Anderson JJ, Simms R, et al. Treatment of patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996;100(3):290-8. doi: 10.1016/S0002-9343(97)89450-8.

Cherico AS, Rizvi A, Jayakrishnan T, et al. Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment. BMJ Case Rep. 2022;15(7):1-4. doi: 10.1136/bcr-2022-249737.

Send T, Spiegel JL, Schade G, et al. Amyloidosis of the Upper Aerodigestive Tract: Management of a Rare Disease and Review of the Literature. Dysphagia. 2019;34(2):179-91. doi:10.1007/s00455-018-9956-x.

 Adamo D, Gasparro R, Marenzi G, et al. Amyloidoma of the Tongue: Case Report, Surgical Management, and Review of the Literature. J Oral Maxillofac Surg. 2020;78(9):1572-82. doi: 10.1016/j.joms.2020.04.022.

Yamasaki Y, Mukaino A, Yamashita S, et al. Macroglossia in rapidly progressive inclusion body myositis. Neuropathology. 2023;43(3):252-6. doi: 10.1111/neup.12879.

Picciani B, Gornic C, Cunha KS, et al. Lingual amyloidosis associated to long-term hemodialysis: Two case reports. Spec Care Dentist. 2018;38(6):434-7. doi: 10.1111/scd.12331.

Ihne S, Morbach C, Sommer C, et al. Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed Disease. Dtsch Arztebl Int. 2020;117(10):159-66. doi: 10.3238/arztebl.2020.0159.

Ryšavá R. AL amyloidosis: advances in diagnostics and treatment. Nephrol Dial Transplant. 2019;34(9):1460-6. doi: 10.1093/ndt/gfy291.

Gertz MA. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment. Am J Hematol. 2022;97(6):818-29. doi: 10.1002/ajh.26569.

Palladini G, Milani P, Merlini G. Management of AL amyloidosis in 2020. Hematology Am Soc Hematol Educ Program. 2020; 2020(1):363-71. doi: 10.1182/hematology.2020006913.